Publications by authors named "Jasmin Beygo"

Article Synopsis
  • - Cornelia de Lange syndrome (CdLS) is a rare genetic disorder that impacts physical development and cognitive abilities, primarily caused by mutations in genes linked to the cohesin complex, though many cases remain undiagnosed.
  • - The study presents a family case where multiple members have an intragenic duplication in the AFF2 gene, identified using advanced genomic technologies like high-resolution array Comparative Genomic Hybridization and next-generation sequencing.
  • - The research shows a clear correlation between the AFF2 gene mutation and the CdLS phenotype, with the affected individuals displaying significant changes in gene expression and X-inactivation patterns compared to an unaffected relative, suggesting that AFF2 should be included in molecular diagnosis for CdLS.
View Article and Find Full Text PDF

Background: Imprinting disorders are rare diseases resulting from altered expression of imprinted genes, which exhibit parent-of-origin-specific expression patterns regulated through differential DNA methylation. A subgroup of patients with imprinting disorders have DNA methylation changes at multiple imprinted loci, a condition referred to as multi-locus imprinting disturbance (MLID). MLID is recognised in most but not all imprinting disorders and is also found in individuals with atypical clinical features; the presence of MLID often alters the management or prognosis of the affected person.

View Article and Find Full Text PDF

Imprinting Disorders (ImpDis) are a group of congenital syndromes associated with up to four different types of molecular disturbances affecting the monoallelic and parent-of-origin specific expression of genomically imprinted genes. Though each ImpDis is characterized by aberrations at a distinct genetic site and a specific set of postnatal clinical signs, there is a broad overlap between several of them. In particular, the prenatal features of ImpDis are non-specific.

View Article and Find Full Text PDF

Multiple synostoses syndrome (OMIM: #186500, #610017, #612961, #617898) is a genetically heterogeneous group of autosomal dominant diseases characterized by abnormal bone unions. The joint fusions frequently involve the hands, feet, elbows or vertebrae. Pathogenic variants in have been associated with multiple synostoses syndrome type 3 (SYNS3).

View Article and Find Full Text PDF

In 2016 and 2018, Chung, Jansen and others described a new syndrome caused by haploinsufficiency of (pleckstrin homology domain interacting protein, OMIM *612,870) and mainly characterized by developmental delay (DD), learning difficulties/intellectual disability (ID), behavioral abnormalities, facial dysmorphism and obesity (CHUJANS, OMIM #617991). So far, alterations appear to be a rare cause of DD/ID. "Omics" technologies such as exome sequencing or array analyses have led to the identification of distinct types of alterations of , including, truncating variants, missense substitutions, splice variants and large deletions encompassing portions of the gene or the entire gene as well as adjacent genomic regions.

View Article and Find Full Text PDF

Background: Imprinting disorders, which affect growth, development, metabolism and neoplasia risk, are caused by genetic or epigenetic changes to genes that are expressed from only one parental allele. Disease may result from changes in coding sequences, copy number changes, uniparental disomy or imprinting defects. Some imprinting disorders are clinically heterogeneous, some are associated with more than one imprinted locus, and some patients have alterations affecting multiple loci.

View Article and Find Full Text PDF
Article Synopsis
  • DNA methylation can be influenced by the environment, leading researchers to explore if psychological therapies can affect these epigenetic processes.
  • A study aimed to replicate changes in DNA methylation related to therapy in monocytes from 60 women with PTSD and to discover new genomic regions affected by therapy using whole-genome sequencing in two patients.
  • Findings showed no significant therapy-related DNA methylation changes in commonly studied genes, and any detected changes in other genomic regions weren’t consistent across the entire patient group, suggesting limited impact of therapy on DNA methylation in PTSD patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study identifies 15 new genetic alterations linked to KCNK9 imprinting syndrome (KIS) by analyzing 47 affected individuals, revealing a diverse genetic and phenotypic spectrum.
  • It highlights common symptoms of KIS, such as motor and speech delays, intellectual disabilities, and behavioral issues, while also discovering an additional mutational hotspot in the gene involved.
  • The research emphasizes that KIS is characterized by complex channel function alterations, which can aid in molecular diagnosis since clinical features alone are insufficient for identification.
View Article and Find Full Text PDF

Background: Beckwith-Wiedemann syndrome (BWS) is a rare overgrowth syndrome characterized by congenital malformations and predisposition to embryonic tumors. Loss of methylation of imprinting center 2 (IC2) is the most frequent alteration and rarely associated with tumors compared to paternal uniparental disomy of chromosome 11 (UPD(11)pat) and gain of methylation of imprinting center 1.

Methods: Our study aimed to describe the clinical, histopathological and genetic characteristics of two patients and establish genotype-phenotype correlations.

View Article and Find Full Text PDF
Article Synopsis
  • Recent research identified FBXO11 gene variants as a cause of a neurodevelopmental disorder (NDD), and analysis of 23 new cases showed a wide range of symptoms, primarily developmental delays and intellectual disability.
  • The study found various mutations, including deletions and missense variants, affecting the FBXO11 protein's structure and function, which often resulted in mislocalization and reduced protein levels.
  • Functional tests indicated that these mutations likely disrupt the normal function of FBXO11, suggesting that haploinsufficiency (having only one functioning copy of the gene) may lead to the observed NDD symptoms.
View Article and Find Full Text PDF

Silver-Russell syndrome (SRS) is characterized by pre- and postnatal growth deficiency. It is most often caused by hypomethylation of the paternal imprinting center 1 of chromosome 11p15.5.

View Article and Find Full Text PDF

Background: MAGEL2-associated Schaaf-Yang syndrome (SHFYNG, OMIM #615547, ORPHA: 398069), which was identified in 2013, is a rare disorder caused by truncating variants of the paternal copy of MAGEL2, which is localized in the imprinted region on 15q11.2q13. The phenotype of SHFYNG in childhood partially overlaps with that of the well-established Prader-Willi syndrome (PWS, OMIM #176270).

View Article and Find Full Text PDF
Article Synopsis
  • Beckwith-Wiedemann syndrome (BWS) is associated with a significant increase in cancer risk due to genetic defects on chromosome 11p15.5, with this study involving 321 diagnosed individuals under 15 years.
  • A total of 13 cancer cases were identified in the BWS cohort, leading to a 33-fold increased risk compared to expected rates, with specific types including hepatoblastoma and nephroblastoma.
  • The highest cancer risk was linked to a genetic condition called paternal uniparental disomy of 11p15.5, while no excessive risk was confirmed for patients with a specific methylation pattern, indicating the need for further research.
View Article and Find Full Text PDF
Article Synopsis
  • - Angelman syndrome (AS) is a rare genetic disorder caused mainly by the loss of the UBE3A gene function, with a small percentage attributed to an imprinting defect affecting certain DNA regions.
  • - Researchers analyzed the AS imprinting center (AS-IC) in 168 patients without deletions and found six common genetic variants, leading to five haplotypes, but no sequence alterations were detected.
  • - In a study involving 119 families, they discovered that haplotype H-AS3, which contains a specific deletion, is significantly linked to an increased risk of the imprinting defect in AS patients, highlighting the importance of the AS-IC in genetic imprinting and disease development.
View Article and Find Full Text PDF
Article Synopsis
  • The article updates the best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes, originally published in 2010.
  • It addresses advancements in techniques, differential diagnoses, and reporting standards since the previous publication.
  • The update aims to clarify the pros and cons of various methods, enhancing the interpretation of results for more standardized reporting.
View Article and Find Full Text PDF

Two distinct genomic disorders have been linked to Xq28-gains, namely Xq28-duplications including MECP2 and Int22h1/Int22h2-mediated duplications involving RAB39B. Here, we describe six unrelated patients, five males and one female, with Xq28-gains distal to MECP2 and proximal to the Int22h1/Int22h2 low copy repeats. Comparison with patients carrying overlapping duplications in the literature defined the MidXq28-duplication syndrome featuring intellectual disability, language impairment, structural brain malformations, microcephaly, seizures and minor craniofacial features.

View Article and Find Full Text PDF

Beckwith-Wiedemann syndrome (BWS; OMIM #130650) is an imprinting disorder caused by genetic or epigenetic alterations of one or both imprinting control regions on chromosome 11p15.5. Hypomethylation of the centromeric imprinting control region (KCNQ1OT1:TSS-DMR, ICR2) is the most common molecular cause of BWS and is present in about half of the cases.

View Article and Find Full Text PDF
Article Synopsis
  • - Temple syndrome (TS14) is a rare genetic disorder linked to chromosome 14q32, resulting from abnormalities in gene imprinting that affect the expression of paternal and maternal genes differently.
  • - A study of 13 TS14 patients showed that the imprinting defect can arise from either grandmaternal or grandpaternal inheritance, pointing to an issue that occurs during the paternal germ line's development after the normal imprinting process is erased.
  • - The findings suggest that while many TS14 patients show a lack of methylation (gene silencing), some cases with mixed methylation patterns imply that these imprinting defects may originate from changes in early embryonic development rather than just genetic inheritance.
View Article and Find Full Text PDF
Article Synopsis
  • Genomic imprinting is a phenomenon where certain genes are expressed in a parent-of-origin-specific manner, and disruptions can lead to imprinting disorders affecting growth, behavior, and metabolism.
  • This study utilized whole-exome sequencing on 38 families with members displaying multilocus imprinting disturbances, revealing 15 new cases linked to harmful variants in maternal effect genes.
  • The findings suggest that maternal genetic factors can impact offspring development, indicating the need for testing for such variants in families with unusual imprinting disorders.*
View Article and Find Full Text PDF

DNA methylation, i.e., the methylation of cytosine at carbon atom C5, has an important role in the regulation of gene expression.

View Article and Find Full Text PDF
Article Synopsis
  • Maternal uniparental disomy of chromosome 6 (upd(6)mat) is rare and its clinical impact is still not well understood, but this study evaluates cases and existing literature to clarify its significance.* -
  • Analysis of new and reported cases showed no common genetic patterns, with some patients having normal chromosomes and others showing trisomy 6 mosaicism, alongside frequent occurrences of intrauterine growth restriction (IUGR) and preterm delivery.* -
  • While upd(6)mat itself does not directly cause specific clinical issues, it may indicate underlying problems, such as placental dysfunction due to trisomy 6, and should be viewed as a biomarker rather than a primary cause of clinical
View Article and Find Full Text PDF
Article Synopsis
  • - The chromosomal region 14q32 has imprinted genes that express from either parental allele, regulated by two types of differentially methylated regions (DMRs): IG-DMR and MEG3-DMR.
  • - Disruption of these imprinted genes can lead to conditions like Temple syndrome (TS14) and Kagami-Ogata syndrome (KOS14).
  • - A third DMR in MEG8 (MEG8-DMR) shows distinct methylation patterns between the two syndromes, suggesting that the activity of the MEG3 promoter may play a critical role in establishing methylation at the MEG8-DMR.
View Article and Find Full Text PDF

Angelman syndrome (AS) is characterized by severe intellectual disability, limited, or absent speech and a generally happy demeanor. The four known etiological mechanisms; deletions, uniparental disomy, imprinting defects, and UBE3A mutation all affect expression of the UBE3A gene at 15q11-q13. An atypical phenotype is seen in individuals who are mosaic for a chromosome 15q11-q13 imprinting defect on the maternal allele.

View Article and Find Full Text PDF

The analysis of DNA methylation has become routine in the pipeline for diagnosis of imprinting disorders, with many publications reporting aberrant methylation associated with imprinted differentially methylated regions (DMRs). However, comparisons between these studies are routinely hampered by the lack of consistency in reporting sites of methylation evaluated. To avoid confusion surrounding nomenclature, special care is needed to communicate results accurately, especially between scientists and other health care professionals.

View Article and Find Full Text PDF